封面
市場調查報告書
商品編碼
1654143

臨床診斷市場規模、佔有率、趨勢分析報告:按產品、應用、最終用途、地區和細分市場預測,2024-2030 年

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床診斷市場的成長和趨勢

根據 Grand View Research, Inc. 的新報告,全球臨床診斷市場規模預計到 2030 年將達到 1,692.3 億美元,2024 年至 2030 年的複合年成長率為 6.6%。

市場成長的動力包括慢性病盛行率的不斷上升、用於早期檢測和疾病管理的專門測試的出現以及對實驗室自動化的不斷成長的需求。此外,照護現場診斷產品的快速應用帶來了醫療保健產業分散化的趨勢。政府投資的增加和對研發的持續重視將推動進一步的成長。

心血管疾病、糖尿病、癌症和呼吸系統疾病等慢性病的流行給全球醫療保健系統帶來了巨大負擔。早期準確的診斷對於有效管理這些疾病至關重要,因此增加了對先進診斷工具和技術的需求。早期發現和準確分期癌症對於成功治療至關重要。臨床診斷透過一系列技術,包括影像檢查(電腦斷層掃描、 MRI、 PET 掃描)、分子診斷(基因測試、液態切片)和腫瘤標記的免疫檢測測定,在癌症篩檢、診斷和監測中發揮至關重要的作用。此外,傳染病檢查領域新產品的採用也促進了市場的成長。例如,2021年3月,FDA透過緊急使用授權(EUA)核准了雅培的BinaxNOW COVID-19 Ag Card快速檢測。這種橫向流免疫檢測旨在快速檢測 COVID-19,它的可用性預計將推動對傳染病檢查產品的需求。

由於採用自動化技術來簡化業務、提高準確性並縮短交貨時間,市場正在快速轉變。自動化可最大限度地降低錯誤風險、提高結果的精確度和準確性、並允許處理大量樣本,從而提高吞吐量。創新自動化照護現場(POC)分析儀的採用有望推動其普及,因為它們提供了經濟高效的測試,並且能夠同時執行多項測試。因此,我們看到採用新產品的明顯趨勢,這一趨勢由於疫情的爆發和支持新型檢測的先進診斷設備的增加而加速。

對高效、可靠的診斷解決方案的需求日益成長,尤其是在新興市場,這推動了對具有成本效益的自動免疫檢測系統的需求。例如,2023年7月,Sysmex公司在Sysmex AACC展會上推出了全新全自動快速化學冷光免疫檢測系統。將免疫檢測分析儀與安全軟體和實驗室資訊系統(LIS)結合,管理員可以控制使用者存取等級並將資料傳輸到其他設備,實現無縫資料傳輸和雲端運算。預計這些進步將在預測期內推動該領域的成長。

此外,政府也為臨床診斷領域的研發投入了大量資金。此外,現在還可以以可負擔的價格提供愛滋病和C型肝炎等慢性病的診斷測試。此外,新興市場(尤其是中國和印度)對醫療服務的需求不斷成長,這兩個市場對臨床檢測的需求尚未得到滿足,這為臨床診斷行業的成長提供了豐厚的機會。

市場的主要企業包括雅培、碧迪 (BD)、西門子醫療、邁瑞醫療國際有限公司、羅氏公司、Sysmex Corporation、Bio-Rad Laboratories 和 Quest Diagnostics, Inc.這些公司正在推行各種策略舉措,包括產品發布和核准,以服務其全球客戶。例如,2023 年 5 月,Becton Dickinson (BD) 的 BD Chiestra抗藥性金黃色葡萄球菌(MRSA) 成像應用獲得了 FDA 510(k) 批准,該應用利用人工智慧 (AI) 軟體。這項技術創新預計將大大縮短檢測結果的周轉時間,成為傳染病檢查市場的寶貴補充。

臨床診斷市場報告重點

  • 按產品分類,設備在 2023 年佔據了最大的收入佔有率。設備在幫助醫療保健專業人員檢測和監測疾病、指導治療決策以及最終改善患者治療效果方面發揮著至關重要的作用。
  • 根據應用,感染疾病佔據市場主導地位,在 2023 年佔據最大佔有率。這是由於技術創新和用於感染疾病檢測的專用檢測套組的日益普及。
  • 根據最終用途,醫院部門在 2023 年佔據最大的市場佔有率。這是因為法醫學和醫院醫學實驗室對臨床診斷的需求不斷增加,包括疾病診斷、血球計數、非法藥物使用檢測、蛋白質分析、血型和治療水平監測。
  • 北美是糖尿病、肥胖、呼吸系統疾病等慢性病發生率較高的地區。這些疾病需要定期監測和診斷測試,因此對先進的診斷工具和技術的需求增加。
  • 預計 2024 年至 2030 年期間亞太地區的複合年成長率將達到 9.0%,為最快的地區。這得歸功於擁有創新設備製造能力和加速診斷研究能力的製造商的存在。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章臨床診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床診斷市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章 臨床診斷市場:按設備的估計和趨勢分析

  • 2023 年及 2030 年設備市場佔有率
  • 細分儀表板
  • 全球臨床診斷市場前景(按設備)
  • 2018-2030 年市場規模、預測及趨勢分析
  • 裝置
    • 血氣分析儀
    • 血液分析儀
    • 臨床化學分析儀
    • 尿液分析儀
    • 凝血分析儀
    • 顯微鏡
    • 流式細胞儀
    • PCR
    • 定序設備
    • 酵素連結免疫吸附試驗
    • 質譜儀
    • 自動盤式分析儀
    • 光強度
    • 離心機
    • 電泳試劑
    • 就地檢驗(POCT) 設備
    • 超音波設備
    • CT(電腦斷層掃描)掃描儀
    • MRI
    • X光設備
    • 其他
  • 試劑
    • Taq聚合酵素
    • MMLV RT
    • HIV RT
    • 熱啟動Taq聚合酵素
    • 聯合國
    • RNase抑制劑
    • Bst聚合酵素
    • PCR 預混液
    • T7 RNA聚合酵素
    • Cas9酶
    • 酸性磷酸酶
    • 丙氨酸胺基轉移酶
    • 澱粉酶
    • 血管收縮素轉化酵素
    • 天門冬胺基轉移酶
    • 膽鹼酯酶
    • 肌酸激酶
    • γ-谷氨醯轉移酶
    • 乳酸脫氫酵素
    • 列寧
    • 葡萄糖氧化酵素/葡萄糖去氫酵素
    • 尿素酶
    • 澱粉酶
    • 乳酸氧化酶
    • 辣根過氧化物
    • 麩胺酸氧化酶
    • 其他
  • 軟體和服務
    • 實驗室資訊管理系統
    • 診斷影像軟體
    • 資料分析軟體
    • 體外診斷藥品的品管
  • 套件和檢測試劑

第 5 章 臨床診斷市場:按應用進行的估計和趨勢分析

  • 2023 年和 2030 年應用市場佔有率
  • 細分儀表板
  • 全球臨床診斷市場應用前景
  • 2018-2030 年市場規模、預測及趨勢分析
  • 感染疾病
    • HIV
    • 困難梭狀芽孢桿菌
    • HBV
    • 呼吸道融合細胞病毒(RSV)
    • 肺炎或鏈球菌感染疾病
    • 流感
    • HCV
    • MRSA
    • 結核病和抗藥性結核病
    • HSV
    • COVID-19
    • 其他感染疾病
  • 腫瘤學
    • 乳癌
    • 大腸直腸癌
    • 子宮頸癌
    • 肺癌
    • 攝護腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰臟癌
    • 卵巢癌
    • 其他
  • 心臟病學
  • 內分泌學
  • 腎臟病學
  • 自體免疫疾病
  • 血液學
  • 毒理學
  • 心臟病學
  • 神經病學

第6章臨床診斷市場:依最終用途的估計與趨勢分析

  • 2023 年及 2030 年終端用途市場佔有率
  • 細分儀表板
  • 全球臨床診斷市場前景(按最終用途分類)
  • 2018-2030 年市場規模、預測及趨勢分析
  • 醫院和診所
    • 住院和門診病人
    • 急診室
  • 診斷實驗室
    • 獨立實驗室
    • 參考實驗室
  • 居家醫療
    • 家庭檢測套組
    • 照護現場設備
  • 公共衛生篩檢項目

第 7 章臨床診斷市場:區域、估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 亞太地區:SWOT 分析
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 2023 年主要企業的市場佔有率分析
    • Abbott
    • bioMerieux SA
    • QuidelOrtho Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen
    • Sysmex Corporation
    • Charles River Laboratories
    • Quest Diagnostics Incorporated
    • BD.
Product Code: GVR-4-68040-495-3

Clinical Diagnostics Market Growth & Trends:

The global clinical diagnostics market size is expected to reach USD 169.23 billion by 2030, registering a CAGR of 6.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is propelled by the growing incidence of chronic diseases, the creation of specialized tests for early detection and disease management, and the rising demand for laboratory automation. Additionally, the rapid adoption of point-of-care diagnostic products has introduced a trend towards decentralization in the healthcare industry. Further growth is driven by increased government investments and ongoing R&D efforts.

The prevalence of chronic conditions, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, pose a substantial burden on healthcare systems worldwide. Early and accurate diagnosis plays a crucial role in managing these diseases effectively, leading to an increased demand for advanced diagnostic tools and technologies. Early detection and accurate staging of cancer are crucial for successful treatment outcomes. Clinical diagnostics play a vital role in cancer screening, diagnosis, and monitoring through various techniques, including imaging tests (CT scans, MRI, PET scans), molecular diagnostics (genetic testing, liquid biopsies), and immunoassays for tumor markers. Furthermore, the introduction of new products in the field of infectious disease testing is contributing to the market's growth. For instance, in March 2021 FDA's Emergency Use Authorization (EUA) granted BinaxNOW COVID-19 Ag Card rapid test by Abbott's. This lateral flow immunoassay is designed for the rapid detection of COVID-19, and its availability is expected to increase demand for infectious disease testing products.

The market is undergoing a rapid transformation as it adopts automation technologies to streamline operations, enhance accuracy, and reduce turnaround time. Automation minimizes the risk of errors and improves the precision and accuracy of results, while also enabling the handling of large volumes of samples, resulting in increased throughput. The introduction of innovative automated point-of-care (POC) analyzers is expected to drive increased adoption, offering cost-effective testing and the ability to conduct multiple tests simultaneously. As a result, there has been a notable trend towards adopting novel products, which has been accelerated by the pandemic and the increased availability of advanced diagnostic instruments that support novel assays.

The demand for cost-effective automated immunoassay systems is on the rise, particularly in developing markets, where there is a growing need for efficient and reliable diagnostic solutions. For instance, in July 2023, Sysmex Corporation introduced a new fully automated and high-speed chemiluminescence immunoassay system in Sysmex AACC exhibition. The integration of security software and Laboratory Information Systems (LIS) with immunoassay analyzers enables administrators to control user access levels and transfer data to other devices, facilitating seamless data transfer and cloud computing. These advancements are expected to drive the growth of the segment over the forecast period.

Presence of government funding programs aimed at reducing the burden of chronic diseases, by funding various clinical trials aimed at, is expected to have a positive impact on the market, In addition governments are allocating substantial funds for research and development (R&D) in the field of clinical diagnostics. In addition, the availability of affordable diagnostic tests for chronic diseases such as AIDS and hepatitis C. Additionally, the rising demand for healthcare services in emerging markets, particularly China and India, where there is a significant unmet need for clinical testing, presents a lucrative opportunity for growth in the clinical diagnostics industry.

Some of the key players in the market are Abbott, Becton Dickinson (BD), Siemens Healthineers, Mindray Medical International Limited, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Bio-Rad Laboratories, and Quest Diagnostics Incorporated. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele. For instance, in May 2023, Becton Dickinson (BD) received FDA 510(k) clearance for its BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) imaging application, which leverages artificial intelligence (AI) software. This innovation is expected to significantly reduce the turnaround time for test results, making it a valuable addition to the market for infectious disease testing.

Clinical Diagnostics Market Report Highlights:

  • Based on product, instruments accounted for the largest revenue share in 2023. Instruments play a crucial role in enabling healthcare professionals to detect and monitor diseases, guide treatment decisions, and ultimately improve patient outcomes.
  • Based on application, infectious diseases dominated the market and accounted for the largest share in 2023.This can be attributed to increasing innovation and availability of specialized test kits for infectious disease detection.
  • Based on end use, hospital segment dominated the end use segments with the largest market share in 2023. This is attributable to growing clinical diagnostics demand in forensic labs and hospital medical labs for disease diagnosis, blood cell counts, detecting illegal drug use, protein analysis, blood typing and monitoring therapeutic drug levels.
  • North America dominated the global market due to the presence of a large number of major market players, North America has a high prevalence of chronic diseases like diabetes, obesity, and respiratory conditions. These diseases require regular monitoring and diagnostic testing, fueling the demand for advanced diagnostic tools and technologies.
  • Asia Pacific is expected to witness the fastest CAGR of 9.0% from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Instruments
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increase in prevalence of chronic diseases
      • 3.2.1.2. Increasing demand for lab automation
      • 3.2.1.3. Development of specialized tests for early disease management
      • 3.2.1.4. Rapid growth of point of care diagnostic products
      • 3.2.1.5. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Clinical Diagnostics Instruments
  • 3.3. Clinical Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Clinical Diagnostics Market: Instruments Estimates & Trend Analysis

  • 4.1. Instruments Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Diagnostics Market by Instruments Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Blood gas analyzers
      • 4.5.2.1. Blood gas analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Hematology analyzers
      • 4.5.3.1. Hematology analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Clinical chemistry analyzers
      • 4.5.4.1. Clinical chemistry analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Urine analyzers
      • 4.5.5.1. Urine analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Coagulation analyzers
      • 4.5.6.1. Coagulation analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Microscopes
      • 4.5.7.1. Microscopes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.8. Flow Cytometers
      • 4.5.8.1. Flow cytometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.9. PCR
      • 4.5.9.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.10. Sequencing Instruments
      • 4.5.10.1. Sequencing Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.11. ELISA
      • 4.5.11.1. ELISA market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.12. Mass Spectrometers
      • 4.5.12.1. Mass Spectrometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.13. Automated Plate Readers
      • 4.5.13.1. Automated plate readers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.14. Spectrophotometers
      • 4.5.14.1. Spectrophotometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.15. Centrifuges
      • 4.5.15.1. Centrifuges market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.16. Electrophoresis Reagents
      • 4.5.16.1. Electrophoresis equipment market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.17. Point-of-Care Testing (POCT) Devices
      • 4.5.17.1. Point-of-Care testing (POCT) devices market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.18. Ultrasound Machines
      • 4.5.18.1. Ultrasound machines market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.19. CT (Computed Tomography) Scanners
      • 4.5.19.1. CT (Computed Tomography) scanners market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.20. MRI
      • 4.5.20.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.21. X-ray Machines
      • 4.5.21.1. X-ray Machines market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.22. Others
      • 4.5.22.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Reagents
    • 4.6.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Taq polymerase
      • 4.6.2.1. Taq polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. MMLV RT
      • 4.6.3.1. MMLV RT market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. HIV RT
      • 4.6.4.1. HIV RT market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Hot start Taq polymerase
      • 4.6.5.1. Hot start Taq polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. UNG
      • 4.6.6.1. UNG market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.7. RNase inhibitors
      • 4.6.7.1. RNase inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.8. Bst polymerase
      • 4.6.8.1. Bst polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.9. PCR master mix
      • 4.6.9.1. PCR master mix market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.10. T7 RNA polymerase
      • 4.6.10.1. T7 RNA polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.11. Cas9 enzyme
      • 4.6.11.1. Cas9 enzyme market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.12. Acid Phosphatase
      • 4.6.12.1. Acid Phosphatase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.13. Alanine aminotransferase
      • 4.6.13.1. Alanine aminotransferase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.14. Amylase
      • 4.6.14.1. Amylase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.15. Angiotensin converting enzyme
      • 4.6.15.1. Angiotensin converting enzyme market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.16. Aspartate aminotransferase
      • 4.6.16.1. Aspartate aminotransferase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.17. Cholinesterase
      • 4.6.17.1. Cholinesterase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.18. Creatinine kinase
      • 4.6.18.1. Creatinine kinase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.19. Gamma glutamyl transferase
      • 4.6.19.1. Gamma glutamyl transferase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.20. Lactate dehydrogenase
      • 4.6.20.1. Lactate dehydrogenase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.21. Renin
      • 4.6.21.1. Renin market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.22. Glucose oxidase/glucose dehydrogenase
      • 4.6.22.1. Glucose oxidase/glucose dehydrogenase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.23. Urease
      • 4.6.23.1. Urease market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.24. Amylase
      • 4.6.24.1. Amylase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.25. Lactate oxidase
      • 4.6.25.1. Lactate oxidase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.26. Horseradish peroxide
      • 4.6.26.1. Horseradish peroxide market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.27. Glutamate Oxidase
      • 4.6.27.1. Glutamate Oxidase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.28. Others
      • 4.6.28.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software and Services
    • 4.7.1. Software and Services market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Laboratory information management systems
      • 4.7.2.1. Laboratory information management systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. Diagnostic imaging software
      • 4.7.3.1. Diagnostic imaging software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.4. Data analysis software
      • 4.7.4.1. Data analysis software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.5. In Vitro Diagnostics Quality Control
      • 4.7.5.1. In Vitro Diagnostics Quality Control market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Kits and assays
    • 4.8.1. Kits and assays market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Diagnostics Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Infectious Disease
    • 5.5.1. Infectious disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. HIV
      • 5.5.2.1. HIV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Clostridium Difficile
      • 5.5.3.1. Clostridium Difficile Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. HBV
      • 5.5.4.1. HBV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Respiratory Syncytial Virus (RSV)
      • 5.5.5.1. Respiratory Syncytial Virus (RSV) Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Pneumonia or Streptococcus Associated Infections
      • 5.5.6.1. Respiratory Syncytial Virus (RSV) Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Influenza/Flu
      • 5.5.7.1. Influenza/Flu Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.8. HCV
      • 5.5.8.1. HCV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.9. MRSA
      • 5.5.9.1. MRSA Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.10. TB and Drug-resistant TB
      • 5.5.10.1. TB and Drug-resistant TB Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.11. HSV
      • 5.5.11.1. HSV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.12. COVID-19
      • 5.5.12.1. COVID-19 Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.13. Other Infectious Diseases
      • 5.5.13.1. Other Infectious Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Breast Cancer
      • 5.6.2.1. Breast Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Colorectal Cancer
      • 5.6.3.1. Colorectal Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Cervical Cancer
      • 5.6.4.1. Cervical Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Lung Cancer
      • 5.6.5.1. Lung Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Prostate Cancer
      • 5.6.6.1. Prostate Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.7. Skin Cancer
      • 5.6.7.1. Skin Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.8. Blood Cancer
      • 5.6.8.1. Blood Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.9. Kidney Cancer
      • 5.6.9.1. Kidney Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.10. Liver Cancer
      • 5.6.10.1. Liver Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.11. Pancreatic Cancer
      • 5.6.11.1. Pancreatic cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.12. Ovarian Cancer
      • 5.6.12.1. Ovarian Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.13. Others
      • 5.6.13.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Cardiology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Endocrinology
    • 5.8.1. Endocrinology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Nephrology
    • 5.9.1. Nephrology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.11. Hematology
    • 5.11.1. Hematology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.12. Toxicology
    • 5.12.1. Toxicology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.13. Cardiology
    • 5.13.1. Cardiology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.14. Neurology
    • 5.14.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Diagnostics Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Inpatient and Outpatient
      • 6.5.2.1. Inpatient and Outpatient Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Emergency Rooms
      • 6.5.3.1. Emergency Rooms Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Diagnostic Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Independent Laboratories
      • 6.6.2.1. Independent Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Reference Laboratories
      • 6.6.3.1. Reference Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Home Care Settings
    • 6.7.1. Home Care Settings Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. At-home Testing Kits
      • 6.7.2.1. At-home Testing Kits Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Point-of-Care Devices
      • 6.7.3.1. Point-of-Care Devices Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Public Health Screening Programs
    • 6.8.1. Public Health Screening Programs Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific: SWOT Analysis
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Services benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. bioMerieux SA
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Services benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. QuidelOrtho Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Services benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Siemens Healthineers AG
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Services benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Thermo Fisher Scientific, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Services benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Agilent Technologies, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Services benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bio-Rad Laboratories, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Services benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Qiagen
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Services benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Sysmex Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Services benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Charles River Laboratories
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Services benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Quest Diagnostics Incorporated
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Services benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. BD.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Services benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 15 Europe Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 18 Germany Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 21 UK Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 24 France Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 27 Italy Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 30 Spain Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 33 Denmark Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 39 Norway Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 China Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 46 China Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 49 Japan Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 52 India Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 South Korea Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 55 South Korea Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 58 Australia Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 64 Latin America Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Brazil Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 66 Brazil Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 67 Brazil Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Mexico Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 69 Mexico Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 70 Mexico Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 73 Argentina Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 77 MEA Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 80 South Africa Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 86 UAE Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Diagnostics, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global clinical diagnostics market, for Product, 2018 - 2030 (USD Million)
  • Fig. 13 Global clinical diagnostics market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 14 Global clinical diagnostics market, for Blood gas analyzers, 2018 - 2030 (USD Million)
  • Fig. 15 Global clinical diagnostics market, for Hematology analyzers, 2018 - 2030 (USD Million)
  • Fig. 16 Global clinical diagnostics market, for Clinical chemistry analyzers, 2018 - 2030 (USD Million)
  • Fig. 17 Global clinical diagnostics market, for Immunoassay analyzers, 2018 - 2030 (USD Million)
  • Fig. 18 Global clinical diagnostics market, for Urine analyzers, 2018 - 2030 (USD Million)
  • Fig. 19 Global clinical diagnostics market, for Coagulation analyzers, 2018 - 2030 (USD Million)
  • Fig. 20 Global clinical diagnostics market, for Microscopes, 2018 - 2030 (USD Million)
  • Fig. 21 Global clinical diagnostics market, for Flow cytometers, 2018 - 2030 (USD Million)
  • Fig. 22 Global clinical diagnostics market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 23 Global clinical diagnostics market, for Sequencing instruments, 2018 - 2030 (USD Million)
  • Fig. 24 Global clinical diagnostics market, for Elisa, 2018 - 2030 (USD Million)
  • Fig. 25 Global clinical diagnostics market, for Mass spectrometers, 2018 - 2030 (USD Million)
  • Fig. 26 Global clinical diagnostics market, for Automated plate readers, 2018 - 2030 (USD Million)
  • Fig. 27 Global clinical diagnostics market, for Spectrophotometers, 2018 - 2030 (USD Million)
  • Fig. 28 Global clinical diagnostics market, for Centrifuges, 2018 - 2030 (USD Million)
  • Fig. 29 Global clinical diagnostics market, for Electrophoresis equipment, 2018 - 2030 (USD Million)
  • Fig. 30 Global clinical diagnostics market, for Point-of-care testing (POCT) devices, 2018 - 2030 (USD Million)
  • Fig. 31 Global clinical diagnostics market, for Ultrasound machines, 2018 - 2030 (USD Million)
  • Fig. 32 Global clinical diagnostics market, for Ct (computed tomography) scanners, 2018 - 2030 (USD Million)
  • Fig. 33 Global clinical diagnostics market, for MRI, 2018 - 2030 (USD Million)
  • Fig. 34 Global clinical diagnostics market, for X-ray machines, 2018 - 2030 (USD Million)
  • Fig. 35 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 36 Global clinical diagnostics market, for Reagents, 2018 - 2030 (USD Million)
  • Fig. 37 Global clinical diagnostics market, for Taq polymerase, 2018 - 2030 (USD Million)
  • Fig. 38 Global clinical diagnostics market, for MMLV RT, 2018 - 2030 (USD Million)
  • Fig. 39 Global clinical diagnostics market, for HIV RT, 2018 - 2030 (USD Million)
  • Fig. 40 Global clinical diagnostics market, for Hot start taq polymerase, 2018 - 2030 (USD Million)
  • Fig. 41 Global clinical diagnostics market, for Ung, 2018 - 2030 (USD Million)
  • Fig. 42 Global clinical diagnostics market, for RNAse inhibitors, 2018 - 2030 (USD Million)
  • Fig. 43 Global clinical diagnostics market, for BST polymerase, 2018 - 2030 (USD Million)
  • Fig. 44 Global clinical diagnostics market, for PCR master mix, 2018 - 2030 (USD Million)
  • Fig. 45 Global clinical diagnostics market, for Lyophilized polymerase, 2018 - 2030 (USD Million)
  • Fig. 46 Global clinical diagnostics market, for T7 RNA polymerase, 2018 - 2030 (USD Million)
  • Fig. 47 Global clinical diagnostics market, for Cas9 enzyme, 2018 - 2030 (USD Million)
  • Fig. 48 Global clinical diagnostics market, for Acid phosphatase, 2018 - 2030 (USD Million)
  • Fig. 49 Global clinical diagnostics market, for Alanine aminotransferase, 2018 - 2030 (USD Million)
  • Fig. 50 Global clinical diagnostics market, for Amylase, 2018 - 2030 (USD Million)
  • Fig. 51 Global clinical diagnostics market, for Angiotensin converting enzyme, 2018 - 2030 (USD Million)
  • Fig. 52 Global clinical diagnostics market, for Aspartate aminotransferase, 2018 - 2030 (USD Million)
  • Fig. 53 Global clinical diagnostics market, for Cholinesterase, 2018 - 2030 (USD Million)
  • Fig. 54 Global clinical diagnostics market, for Creatinine kinase, 2018 - 2030 (USD Million)
  • Fig. 55 Global clinical diagnostics market, for Gamma glutamyl transferase, 2018 - 2030 (USD Million)
  • Fig. 56 Global clinical diagnostics market, for Lactate dehydrogenase, 2018 - 2030 (USD Million)
  • Fig. 57 Global clinical diagnostics market, for Renin, 2018 - 2030 (USD Million)
  • Fig. 58 Global clinical diagnostics market, for Glucose oxidase/glucose dehydrogenase, 2018 - 2030 (USD Million)
  • Fig. 59 Global clinical diagnostics market, for Urease, 2018 - 2030 (USD Million)
  • Fig. 60 Global clinical diagnostics market, for Lactate oxidase, 2018 - 2030 (USD Million)
  • Fig. 61 Global clinical diagnostics market, for Horseradish peroxide, 2018 - 2030 (USD Million)
  • Fig. 62 Global clinical diagnostics market, for Glutamate oxidase, 2018 - 2030 (USD Million)
  • Fig. 63 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 64 Global clinical diagnostics market, for Software and services, 2018 - 2030 (USD Million)
  • Fig. 65 Global clinical diagnostics market, for Laboratory information management systems, 2018 - 2030 (USD Million)
  • Fig. 66 Global clinical diagnostics market, for Diagnostic imaging software, 2018 - 2030 (USD Million)
  • Fig. 67 Global clinical diagnostics market, for Data analysis software, 2018 - 2030 (USD Million)
  • Fig. 68 Global clinical diagnostics market, for In vitro diagnostics quality control, 2018 - 2030 (USD Million)
  • Fig. 69 Global clinical diagnostics market, for Kits and assays, 2018 - 2030 (USD Million)
  • Fig. 70 Global clinical diagnostics market, for Application, 2018 - 2030 (USD Million)
  • Fig. 71 Global clinical diagnostics market, for Infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 72 Global clinical diagnostics market, for HIV, 2018 - 2030 (USD Million)
  • Fig. 73 Global clinical diagnostics market, for Clostridium difficile, 2018 - 2030 (USD Million)
  • Fig. 74 Global clinical diagnostics market, for HBV, 2018 - 2030 (USD Million)
  • Fig. 75 Global clinical diagnostics market, for Pneumonia or Streptococcus Associated Infections, 2018 - 2030 (USD Million)
  • Fig. 76 Global clinical diagnostics market, for Respiratory Syncytial Virus (RSV), 2018 - 2030 (USD Million)
  • Fig. 77 Global clinical diagnostics market, for HPV, 2018 - 2030 (USD Million)
  • Fig. 78 Global clinical diagnostics market, for Influenza/Flu, 2018 - 2030 (USD Million)
  • Fig. 79 Global clinical diagnostics market, for HCV, 2018 - 2030 (USD Million)
  • Fig. 80 Global clinical diagnostics market, for MRSA, 2018 - 2030 (USD Million)
  • Fig. 81 Global clinical diagnostics market, for TB and drug-resistant TB, 2018 - 2030 (USD Million)
  • Fig. 82 Global clinical diagnostics market, for HSV, 2018 - 2030 (USD Million)
  • Fig. 83 Global clinical diagnostics market, for COVID-19, 2018 - 2030 (USD Million)
  • Fig. 84 Global clinical diagnostics market, for Other infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 85 Global clinical diagnostics market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 86 Global clinical diagnostics market, for Breast cancer, 2018 - 2030 (USD Million)
  • Fig. 87 Global clinical diagnostics market, for Colorectal cancer, 2018 - 2030 (USD Million)
  • Fig. 88 Global clinical diagnostics market, for Cervical cancer, 2018 - 2030 (USD Million)
  • Fig. 89 Global clinical diagnostics market, for Lung cancer, 2018 - 2030 (USD Million)
  • Fig. 90 Global clinical diagnostics market, for Prostate cancer, 2018 - 2030 (USD Million)
  • Fig. 91 Global clinical diagnostics market, for Skin cancer, 2018 - 2030 (USD Million)
  • Fig. 92 Global clinical diagnostics market, for Blood cancer, 2018 - 2030 (USD Million)
  • Fig. 93 Global clinical diagnostics market, for Kidney cancer, 2018 - 2030 (USD Million)
  • Fig. 94 Global clinical diagnostics market, for Liver cancer, 2018 - 2030 (USD Million)
  • Fig. 95 Global clinical diagnostics market, for Pancreatic cancer, 2018 - 2030 (USD Million)
  • Fig. 96 Global clinical diagnostics market, for Ovarian cancer, 2018 - 2030 (USD Million)
  • Fig. 97 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 98 Global clinical diagnostics market, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 99 Global clinical diagnostics market, for Endocrinology, 2018 - 2030 (USD Million)
  • Fig. 100 Global clinical diagnostics market, for Nephrology, 2018 - 2030 (USD Million)
  • Fig. 101 Global clinical diagnostics market, for Autoimmune diseases, 2018 - 2030 (USD Million)
  • Fig. 102 Global clinical diagnostics market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 103 Global clinical diagnostics market, for Toxicology, 2018 - 2030 (USD Million)
  • Fig. 104 Global clinical diagnostics market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 105 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 106 Global clinical diagnostics market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 107 Global clinical diagnostics market, for Hospitals and Clinics, 2018 - 2030 (USD Million)
  • Fig. 108 Global clinical diagnostics market, for Inpatient and Outpatient, 2018 - 2030 (USD Million)
  • Fig. 109 Global clinical diagnostics market, for Emergency Rooms, 2018 - 2030 (USD Million)
  • Fig. 110 Global clinical diagnostics market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 111 Global clinical diagnostics market, for Independent Laboratories, 2018 - 2030 (USD Million)
  • Fig. 112 Global clinical diagnostics market, Reference Laboratories 2018 - 2030 (USD Million)
  • Fig. 113 Global clinical diagnostics market, Home Care Settings 2018 - 2030 (USD Million)
  • Fig. 114 Global clinical diagnostics market, At-home Testing Kits 2018 - 2030 (USD Million)
  • Fig. 115 Global clinical diagnostics market, Point-of-Care Devices 2018 - 2030 (USD Million)
  • Fig. 116 Global clinical diagnostics market, Public Health Screening Programs 2018 - 2030 (USD Million)
  • Fig. 117 Regional Outlook, 2023 & 2030
  • Fig. 118 North America Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 U.S. Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Canada Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Mexico Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Europe Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Germany Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 UK Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 125 France Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 126 Italy Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Spain Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Denmark Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Sweden Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 130 Norway Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 Asia Pacific Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 132 Japan Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 133 China Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 134 India Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 135 Australia Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 South Korea Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 137 Thailand Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 138 Latin America Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 139 Brazil Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 140 Argentina Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 141 Middle East and Africa Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 142 South Africa Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Saudi Arabia Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 144 UAE Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 145 Kuwait Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)